(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.
(CIDRAP News) After a 2-year study of the effects of large-scale farm animal production, a panel of experts has called for phasing out the nontherapeutic use of antimicrobials in farm animals in order to maintain the effectiveness of antibiotics in humans.
(CIDRAP News) – An H5N1 influenza vaccine made by the British pharmaceutical company GlaxoSmithKline (GSK) has become the first prepandemic vaccine to be licensed by the European Union (EU), the company announced today.
(CIDRAP News) Sanofi Pasteur pledged today to give 60 million doses of H5N1 influenza vaccine over 3 years to the World Health Organization (WHO) for a planned stockpile to help poor countries in the event of an influenza pandemic.
(CIDRAP News) Australian authorities have approved an H5N1 avian influenza vaccine made by the Australian-based pharmaceutical company CSL Limited, giving the country a home-grown defensive tool if the virus evolves into a pandemic strain.
(CIDRAP News) The Government Accountability Office (GAO) recently released a report examining the results several developed nations and the European Union achieved when they consolidated oversight of food safety in a single agency, a step often advocated in the United State for solving some of the problems linked to contaminated imported and domestic food.